Breaking News Instant updates and real-time market news.

GLMD

Galmed

$5.45

-4.01 (-42.39%)

07:58
02/15/18
02/15
07:58
02/15/18
07:58

Galmed downgraded to Hold at Maxim after failed ARRIVE study

As reported earlier, Maxim analyst Jason McCarthy downgraded Galmed to Hold from Buy after the company's top-line results from ARRIVE phase 2a study did not meet its primary endpoint. The analyst adds however that the failure of Aramchol in HIV patients does not mean it will fail in the upcoming phase 2b ARREST study with 248 NASH patients, noting that the expected outcome from that trial in Q1 will be the next major event for Galmed.

  • 15

    Feb

GLMD Galmed
$5.45

-4.01 (-42.39%)

11/15/17
ROTH
11/15/17
INITIATION
Target $32
ROTH
Buy
Galmed initiated with a Buy at Roth Capital
Roth Capital analyst Yasmeen Rahimi started Galmed with a Buy rating and $32 price target based on his confidence in the clinical success and profitability of the company's lead compound for the treatment of fatty liver disease, medically referred as non-alcoholic hepatosteatosis.
02/12/18
HCWC
02/12/18
NO CHANGE
Target $24
HCWC
Buy
Galmed price target raised to $24 from $18 at H.C. Wainwright
H.C. Wainwright analyst Ed Arce raised his price target for Galmed Pharmaceuticals to $24 ahead of "transformational" near-term readouts. The analyst expects the imminent results of the Phase 2a Arrive study to establish aramchol as a viable anti-steatosis drug for nonalcoholic steatohepatitis. He's "confident in the successful outcome" and affirms a Buy rating on Galmed ahead of the news.
02/14/18
MAXM
02/14/18
DOWNGRADE
MAXM
Hold
Galmed downgraded to Hold from Buy at Maxim
02/15/18
HCWC
02/15/18
NO CHANGE
HCWC
Buy
Galmed selloff yesterday 'way overdone,' says H.C. Wainwright
H.C. Wainwright analyst Ed Arce views the selloff yesterday in shares of Galmed Pharmaceuticals is "way overdone." The analyst believes the failed Arrive trial should only carry a minor impact to the shares and sees no negative read throughs to the Arrest study. Arrive was an investigator-initiated trial, conducted at a single site by Professor Rohit Loomba, Acre tells investors in a research note. This was never Galmed's study to begin with, so its failure is not its own, the analyst contends. He remains focused on the Q2 readout of Arrest in NASH patients and keeps a Buy rating on Galmed with a $24 price target.

TODAY'S FREE FLY STORIES

BNFT

Benefitfocus

$49.88

-1.99 (-3.84%)

20:44
12/18/18
12/18
20:44
12/18/18
20:44
Hot Stocks
Benefitfocus sees FY19 revenue growth in 'mid-to-high teens' »

Sees FY19 gross margin…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Dec

AGCO

Agco

$56.59

2.7 (5.01%)

20:36
12/18/18
12/18
20:36
12/18/18
20:36
Earnings
Agco guides initial FY19 EPS ~$4.60, consensus $4.59 »

Sees FY19 revenue around…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Dec

NVS

Novartis

$85.40

-0.4 (-0.47%)

20:28
12/18/18
12/18
20:28
12/18/18
20:28
Hot Stocks
Novartis announces licensing of pradigastat to Anji Pharmaceuticals »

Anji Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Jan

SQ

Square

$59.91

1.28 (2.18%)

20:25
12/18/18
12/18
20:25
12/18/18
20:25
Recommendations
Square analyst commentary at Tigress Financial »

Square offers continued…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Dec

PAYX

Paychex

$64.32

-0.63 (-0.97%)

, GIS

General Mills

$36.70

-0.03 (-0.08%)

20:25
12/18/18
12/18
20:25
12/18/18
20:25
Earnings
Notable companies reporting before tomorrow's open »

Notable companies…

PAYX

Paychex

$64.32

-0.63 (-0.97%)

GIS

General Mills

$36.70

-0.03 (-0.08%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Dec

  • 19

    Dec

FSNUY

Fresenius SE

$0.00

(0.00%)

20:21
12/18/18
12/18
20:21
12/18/18
20:21
Upgrade
Fresenius SE rating change at Goldman Sachs »

Fresenius SE upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BNFT

Benefitfocus

$49.88

-1.99 (-3.84%)

20:19
12/18/18
12/18
20:19
12/18/18
20:19
Recommendations
Benefitfocus analyst commentary at Jefferies »

Benefitfocus analyst day…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Dec

FN

Fabrinet

$51.13

2.17 (4.43%)

20:06
12/18/18
12/18
20:06
12/18/18
20:06
Recommendations
Fabrinet analyst commentary at Piper Jaffray »

Fabrinet among the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SEE

Sealed Air

$33.96

0.17 (0.50%)

19:38
12/18/18
12/18
19:38
12/18/18
19:38
Upgrade
Sealed Air rating change at BMO Capital »

Sealed Air upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CAT

Caterpillar

$124.29

-0.2 (-0.16%)

19:31
12/18/18
12/18
19:31
12/18/18
19:31
Hot Stocks
Vice President of Caterpillar Excavation unit to step down »

Caterpillar announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XOM

Exxon Mobil

$71.99

-2.01 (-2.72%)

19:10
12/18/18
12/18
19:10
12/18/18
19:10
Periodicals
Exxon tells EPA it opposes weakening Obama-era emissions rules, Reuters says »

Exxon Mobil issued a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Feb

CBS

CBS

$46.21

-0.6 (-1.28%)

, DIS

Disney

$109.43

-1.2 (-1.08%)

19:07
12/18/18
12/18
19:07
12/18/18
19:07
Periodicals
CBS poised to ramp up CEO search after denying Moonves severance, Bloomberg says »

CBS's (CBS) board is…

CBS

CBS

$46.21

-0.6 (-1.28%)

DIS

Disney

$109.43

-1.2 (-1.08%)

FOX

21st Century Fox

$48.49

-0.29 (-0.59%)

FOXA

21st Century Fox

$48.78

-0.22 (-0.45%)

TRCO

Tribune Media

$45.25

-0.08 (-0.18%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Dec

  • 20

    Dec

  • 05

    Feb

JBL

Jabil

$22.21

0.65 (3.01%)

, SCS

Steelcase

$14.19

0.02 (0.14%)

19:02
12/18/18
12/18
19:02
12/18/18
19:02
Hot Stocks
Fly Intel: After Hours Movers »

UP AFTER EARNINGS: Jabil…

JBL

Jabil

$22.21

0.65 (3.01%)

SCS

Steelcase

$14.19

0.02 (0.14%)

ADMS

Adamas Pharmaceuticals

$8.11

-0.67 (-7.63%)

ANGI

Angi Homeservices

$15.64

-0.01 (-0.06%)

MU

Micron

$34.12

0.23 (0.68%)

LRCX

Lam Research

$138.01

2.39 (1.76%)

AMAT

Applied Materials

$33.27

0.62 (1.90%)

FDX

FedEx

$185.01

2.81 (1.54%)

UPS

UPS

$97.25

0.33 (0.34%)

SURF

Surface Oncology

$7.35

-0.44 (-5.65%)

GSAT

Globalstar

$0.36

0.0082 (2.34%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Dec

  • 18

    Dec

  • 18

    Dec

  • 19

    Dec

  • 08

    Jan

  • 19

    Dec

CBS

CBS

$46.21

-0.6 (-1.28%)

18:45
12/18/18
12/18
18:45
12/18/18
18:45
Periodicals
CBS poised to ramp up CEO search after denying Moonves severance, Bloomberg says »

CBS's board is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Dec

  • 20

    Dec

AMTB

Mercantil Bank

$12.00

-0.3 (-2.44%)

18:41
12/18/18
12/18
18:41
12/18/18
18:41
Syndicate
Mercantil Bank 6.3M share IPO priced at $13.00 per share »

The deal priced below the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Dec

QDEL

Quidel

$50.00

0.9 (1.83%)

18:39
12/18/18
12/18
18:39
12/18/18
18:39
Hot Stocks
Quidel receives CE Mark for Sofia 2 Lyme+ FIA for use with Sofia 2 instrument »

Quidel Corporation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AAOI

Applied Optoelectronics

$15.40

-1.73 (-10.10%)

, ACIA

Acacia Communications

$39.32

-0.53 (-1.33%)

18:34
12/18/18
12/18
18:34
12/18/18
18:34
Recommendations
Applied Optoelectronics, Acacia Communications, Cisco, Fabrinet, Finisar analyst commentary at Piper Jaffray »

Cisco's Luxtera deal…

AAOI

Applied Optoelectronics

$15.40

-1.73 (-10.10%)

ACIA

Acacia Communications

$39.32

-0.53 (-1.33%)

CSCO

Cisco

$44.05

-0.16 (-0.36%)

FN

Fabrinet

$51.13

2.17 (4.43%)

FNSR

Finisar

$21.57

0.005 (0.02%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Jan

  • 04

    Mar

WGO

Winnebago

$19.96

-0.73 (-3.53%)

18:20
12/18/18
12/18
18:20
12/18/18
18:20
Hot Stocks
Winnebago to withdraw its Chicago Stock Exchange listing »

Winnebago Industrie…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Dec

CVS

CVS Health

$69.55

-1.12 (-1.58%)

, AET

Aetna

$0.00

(0.00%)

18:07
12/18/18
12/18
18:07
12/18/18
18:07
Periodicals
Judge weighs naming monitor to oversee CVS during court process, Reuters says »

Judge Richard Leon of the…

CVS

CVS Health

$69.55

-1.12 (-1.58%)

AET

Aetna

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Jan

FDX

FedEx

$185.01

2.81 (1.54%)

, AMZN

Amazon.com

$1,551.00

29.66 (1.95%)

18:05
12/18/18
12/18
18:05
12/18/18
18:05
Hot Stocks
FedEx sees no impact from Amazon's air freight ops »

FedEx (FDX) says it is…

FDX

FedEx

$185.01

2.81 (1.54%)

AMZN

Amazon.com

$1,551.00

29.66 (1.95%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Dec

  • 18

    Dec

  • 19

    Dec

  • 20

    Dec

  • 04

    Jan

  • 07

    Jan

VZ

Verizon

$55.67

-0.29 (-0.52%)

18:04
12/18/18
12/18
18:04
12/18/18
18:04
Hot Stocks
Verizon Media Group will replace the Oath brand »

Oath COO Guru Gowrappan …

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Jan

CE

Celanese

$85.39

0.98 (1.16%)

18:02
12/18/18
12/18
18:02
12/18/18
18:02
Hot Stocks
Celanese raises GUR and GHR grades engineered materials prices by 10% »

Celanese announced price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FDX

FedEx

$185.01

2.81 (1.54%)

17:55
12/18/18
12/18
17:55
12/18/18
17:55
Hot Stocks
Breaking Hot Stocks news story on FedEx »

FedEx says profit…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Dec

FDX

FedEx

$185.01

2.81 (1.54%)

17:52
12/18/18
12/18
17:52
12/18/18
17:52
Hot Stocks
FedEx sees voluntary buyout saving company $225M-$275M in FY20 »

Sees 18-24 month payback…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Dec

VVV

Valvoline

$19.00

0.21 (1.12%)

17:51
12/18/18
12/18
17:51
12/18/18
17:51
Hot Stocks
Valvoline to open 17 acquired Quick-Lube centers in California »

Valvoline Inc. - a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.